Key facts
- This page summarizes David W. Dorman's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 May 2022, 19:33.
David W. Dorman - 11 May 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- Director
- Issuer ticker
- CVS
- Reported as of
- 11 May 2022
- Net transaction value
- +$4,997
- SEC form
- 4
- Accepted by SEC
- 13 May 2022, 19:33:35 UTC
- Prior SEC filing
- 09 Feb 2022
- Next SEC filing
- 03 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David W. Dorman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David W. Dorman filed Form 4 for CVS HEALTH Corp (CVS) on 13 May 2022.
Change
- Previous filing in this sequence was filed on 09 Feb 2022.
- Current net transaction value: +$4,997.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Award
- Transaction value
- $4,997
- Shares
- +51
- Change %
- +0.05%
- Price
- $97.99
- Shares after
- 109,875
- Date
- 11 May 2022
- Ownership
- Direct
- Footnotes
- F1
CVS
holding
Common Stock (By Trust)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 37,700
- Date
- 11 May 2022
- Ownership
- Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
holding
Derivative
Share Credits
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,849
- Date
- 11 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,849
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
David W. Dorman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
Footnote F2
Consists of deferred stock compensation payable pursuant to Reporting Person's election.